Polat, M. Et Al. 2022. Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents. JOURNAL OF CHEMOTHERAPY , vol.34, no.2 , 97-102.

Polat, M., Ozkaya-Parlakay, A., Tapisiz, A., Kara, S. S., & YÜKSEL, S., (2022). Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents. JOURNAL OF CHEMOTHERAPY , vol.34, no.2, 97-102.

Polat, MELTEM Et Al. "Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents," JOURNAL OF CHEMOTHERAPY , vol.34, no.2, 97-102, 2022

Polat, MELTEM Et Al. "Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents." JOURNAL OF CHEMOTHERAPY , vol.34, no.2, pp.97-102, 2022

Polat, M. Et Al. (2022) . "Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents." JOURNAL OF CHEMOTHERAPY , vol.34, no.2, pp.97-102.

@article{article, author={MELTEM POLAT Et Al. }, title={Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents}, journal={JOURNAL OF CHEMOTHERAPY}, year=2022, pages={97-102} }